Algeta ASA : Algeta - Notice of Annual General Meeting 2013

         Algeta ASA : Algeta - Notice of Annual General Meeting 2013

Oslo, Norway, 19 March 2013 - Algeta ASA (OSE: ALGETA), a company focused on
the development of novel targeted cancer therapeutics, announces its Annual
General Meeting 2013:

Algeta's Annual General Meeting will be held on 11 April 2013 at 16:00 hours
(CET) at the offices of Algeta ASA at Kjelsåsveien 172A, Oslo, Norway.

Please find attached the Notice of Algeta ASA's Annual General Meeting,
proposed amended charter for the nomination committee, and attendance slip and
proxy form. These are, together with the annual report, also available on in the Investor section.


For further information, please contact:

Mike Booth / Renate Birkeli          +47 23 00 67 32
Communications & Corporate Affairs
Media enquiries:
Mark Swallow                         +44 207 638 9571
Citigate Dewe Rogerson     
Knut Ekern                           +47 22 04 82 00
Gambit Hill & Knowlton     
Kari Watson                          +1 781 235 3060
MacDougall Biomedical Communications 
US investor enquiries:
Tricia Swanson                       +1 646 378 2953
The Trout Group            

About Algeta

Algeta is a company focused on developing novel targeted therapies for
patients with cancer based on its alpha-pharmaceutical platform. The Company
is headquartered in Oslo, Norway, and has a US subsidiary, Algeta US, LLC,
based in Cambridge, MA performing commercial marketing operations in the US.
Algeta is listed on the Oslo Stock Exchange (Ticker: ALGETA). For more
information please visit

This information is subject of the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.
Proposed amended charter for the Nomination Committee
Attendance and proxy form
Notice of Attendance of Annual General Meeting in Algeta ASA


This announcement is distributed by Thomson Reuters on behalf of Thomson
Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.

Source: Algeta ASA via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.